With expertise in research, fundraising, policy and more, our staff are dedicated to making breakthroughs possible. Hilary Evans-Newton is the Chief Executive of Alzheimer’s Research UK. Hilary joined ...

Two new medications, called lecanemab and donanemab, have shown success in clinical trials in slowing down Alzheimer’s disease. These are known as disease-modifying treatments and have been licensed ...

There are two main types of Alzheimer’s. Late onset Alzheimer’s starts after age 65, and young onset Alzheimer’s affects people before age 65. Different genes can be involved in the development of the ...

If you already have a place in this event but would like to support Alzheimer’s Research UK, we’d love to have you on the team! There’s no minimum sponsorship target and we can provide help and ...

If you already have a place in this event but would like to support Alzheimer’s Research UK, we’d love to have you on the team! There’s no minimum sponsorship target and we can provide help and ...

For the majority of people, genes are only one of many factors that may increase their risk of getting dementia. Other factors that affect our dementia risk include our age, lifestyle and environment.

Gavin Patterson joins Alzheimer's Research UK as chair. The former President and Chief Revenue Officer of Salesforce and CEO ...

Research has found that people who led an active lifestyle, especially before 50 years old, had better brain health aged 70.

Pauline Quirke MBE has been diagnosed with dementia, her husband has announced. The 65-year-old actress, best known for ...

READ-OUT is a new study underway trialling different types of blood tests in different groups of people across the UK ...

Welcome to the Thames Valley Network Centre. The Network Centre unites dementia researchers across the Universities of Oxford, Reading and Oxford Brookes. Here you can find out more about Network ...